Pancreatic adenocarcinoma

1 paper

In silico1

Trial sponsors

Revolution Medicines
Company1 trialPhase 3670 people
Actuate Therapeutics
Company1 trialPhase 2350 people
Fate Therapeutics
Company1 trialPhase 2350 people
Roche
Company2 trialsPhase 1/2344 people
Pfizer
Company1 trialPhase 1540 people
Astellas Pharma
Company1 trialPhase 1398 people
Philogen
Company1 trialPhase 196 people
Light Chain Bioscience - Novimmune
Company1 trialPhase 170 people

Latest

1 in 12 months

bioRxiv2 Feb

Transcriptomics-based modeling of methionine metabolism effectively estimates sample-wise DNA methylation activity and epigenetic aging

Preprint: computational studyBiomarkers

Aging8 Jun

Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression

Experiments in animalsMechanisms